價格 | 詢價 | ||
包裝 | 1支 | 5支 | 10支 |
最小起訂量 | 1支 |
發(fā)貨地 | 北京 |
更新日期 | 2024-12-16 |
中文名稱:TIGIT試劑盒 | 英文名稱:TIGIT ELISA Kit |
品牌: 百普賽斯 | 產(chǎn)地: 北京 |
保存條件: -20°C to -70°C | 純度規(guī)格: 99.9% |
產(chǎn)品類別: ELISA試劑盒 | |
數(shù)量: 999 | 保質(zhì)期: 12個月 |
貨號: EP-131 | 是否進(jìn)口: 否 |
適應(yīng)物種: Human |
背景(Background)
CD155 and ITIM domains (TIGIT) is a novel type of immune checkpoint. CD155 is an adhesion molecule that is upregulated during tumor progression and promotes the proliferative and migratory abilities of tumor cells via various pathways. TIGIT, an inhibitory receptor, is mainly expressed on natural killer (NK), CD8+ T, CD4+ T and T regulatory (Treg) cells. CD155 transmits immune signals via interacting with the inhibitory checkpoint receptor TIGIT, thereby inhibiting the function of T and NK cells.CD155 is highly expressed on the surface of DC cells. When TIGIT on T cells binds to CD155 on DC cells, CD155 will send signals to DC cells to up-regulate the secretion of IL-10 and down-regulate the secretion of IL-12, thereby weakening the immune response mediated by DC cells. DC cells are important antigen-presenting cells in the body, and reduced DC cell activity in turn reduces T cell activity.
原理(Assay Principles)
This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new TIGIT pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human CD155 to immobilized human TIGIT in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated CD155 protein, a human TIGIT protein, an anti-TIGIT neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.
Your experiment will include 4 simple steps:
a) Coat the plate with human TIGIT.
b) Add your molecule of interest to the tests.
c) Add human CD155-Biotin to bind the coated human TIGIT.
d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
e) Finally, the half maximal inhibitory concentration (IC50) of your compound to TIGIT: CD155 binding will be determined by comparing OD readings among different experimental groups.
應(yīng)用說明(Application)
This kit is developed for screening for inhibitors of human TIGIT binding to human CD155.
It is for research use only.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
存儲(Storage)
Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
成立日期 | 2010-07-22 (15年) | 注冊資本 | 8000萬人民幣 |
員工人數(shù) | 500人以上 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥24640.00 |
VIP9年
|
北京索萊寶科技有限公司
|
2025-01-17 | |
¥1200 |
VIP4年
|
上海雅吉生物科技有限公司
|
2025-01-17 | |
¥1950 |
VIP3年
|
上海滬震實(shí)業(yè)有限公司
|
2025-01-17 |